Central NUCB2/Nesfatin-1-Expressing Neurones Belong to the Hypothalamic-Brainstem Circuitry Activated by Hypoglycaemia

Journal of Neuroendocrinology

Volumn 25, Issue 1, 2013, Pages 1-13

  Bonnet, M S ^a   Djelloul, M ^a   Tillement, V ^a   Tardivel, C ^a   Mounien, L ^a   Trouslard, J ^a   Troadec, J D ^a   Dallaporta, M ^a  

^a Aix Marseille University   (France)

Author keywords

2 deoxyglucose; C Fos; Hypoglycaemia; Insulin; Nesfatin 1

Indexed keywords

AMINO ACID; GLUCOSE; NESFATIN 1; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY LABELING; ARTICLE; BRAIN STEM; CONTROLLED STUDY; GLUCOSE BRAIN LEVEL; HYPOGLYCEMIA; HYPOTHALAMUS; MALE; NERVE CELL; NONHUMAN; PREGANGLIONIC NERVE CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; SOLITARY TRACT NUCLEUS; VAGUS NERVE;

ANIMALS; BRAIN STEM; CALCIUM-BINDING PROTEINS; DNA-BINDING PROTEINS; HYPOGLYCEMIA; HYPOTHALAMUS; INSULIN; MALE; NERVE TISSUE PROTEINS; NEURAL PATHWAYS; NEURONS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR;

EID: 84871509865     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2012.02375.x     Document Type: Article

References (54)

1. Oh-I S, Shimizu H, Satoh T, Okada S, Adachi S, Inoue K, Eguchi H, Yamamoto M, Imaki T, Hashimoto K, Tsuchiya T, Monden T, Horiguchi K, Yamada M, Mori M. Identification of nesfatin-1 as a satiety molecule in the hypothalamus. Nature 2006; 443: 709-712.
2. Shimizu H, Oh-I S, Hashimoto K, Nakata M, Yamamoto S, Yoshida N, Eguchi H, Kato I, Inoue K, Satoh T, Okada S, Yamada M, Yada T, Mori M. Peripheral administration of nesfatin-1 reduces food intake in mice: the leptin-independent mechanism. Endocrinology 2009; 150: 662-671.
3. Goebel M, Stengel A, Wang L, Lambrecht NW, Taché Y. Nesfatin-1 immunoreactivity in rat brain and spinal cord autonomic nuclei. Neurosci Lett 2009a; 452: 241-246.
4. Kohno D, Nakata M, Maejima Y, Shimizu H, Sedbazar U, Yoshida N, Dezaki K, Onaka T, Mori M, Yada T. Nesfatin-1 neurons in paraventricular and supraoptic nuclei of the rat hypothalamus coexpress oxytocin and vasopressin and are activated by refeeding. Endocrinology 2008; 149: 1295-1301.
5. Noetzel S, Stengel A, Inhoff T, Goebel M, Wisser AS, Bannert N, Wiedenmann B, Klapp BF, Taché Y, Mönnikes H, Kobelt P. CCK-8S activates c-Fos in a dose-dependent manner in nesfatin-1 immunoreactive neurons in the paraventricular nucleus of the hypothalamus and in the nucleus of the solitary tract of the brainstem. Regul Pept 2009; 157: 84-91.
6. Yosten GL, Redlinger L, Samson WK. Evidence for a role of endogenous nesfatin-1 in the control of water drinking. J Neuroendocrinol 2012; 24: 1078-1084.
7. Könczöl K, Pintér O, Ferenczi S, Varga J, Kovács K, Palkovits M, Zelena D, Tóth ZE. Nesfatin-1 exerts long-term effect on food intake and body temperature. Int J Obes (Lond) 2012; doi: 10.1038/ijo.2012.2
8. Stengel A, Goebel M, Wang L, Rivier J, Kobelt P, Mönnikes H, Lambrecht NW, Taché Y. Central nesfatin-1 reduces dark-phase food intake and gastric emptying in rats: differential role of corticotropin-releasing factor2 receptor. Endocrinology 2009a; 150: 4911-4919.
9. Yosten GL, Samson WK. Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. Am J Physiol Regul Integr Comp Physiol 2009; 297: R330-R336.
10. Yosten GL, Samson WK. The anorexigenic and hypertensive effects of nesfatin-1 are reversed by pretreatment with an oxytocin receptor antagonist. Am J Physiol Regul Integr Comp Physiol 2010; 298: R1642-R1647.
11. Yamawaki H, Takahashi M, Mukohda M, Morita T, Okada M, Hara Y. A novel adipocytokine, nesfatin-1 modulates peripheral arterial contractility and blood pressure in rats. Biochem Biophys Res Commun 2012; 418: 676-681.
12. Goebel M, Stengel A, Wang L, Taché Y. Restraint stress activates nesfatin-1-immunoreactive brain nuclei in rats. Brain Res 2009b; 1300: 114-124.
13. Könczöl K, Bodnár I, Zelena D, Pintér O, Papp RS, Palkovits M, Nagy GM, Tóth ZE. Nesfatin-1/NUCB2 may participate in the activation of the hypothalamic-pituitary-adrenal axis in rats. Neurochem Int 2010; 57: 189-197.
14. Okere B, Xu L, Roubos EW, Sonetti D, Kozicz T. Restraint stress alters the secretory activity of neurons co-expressing urocortin-1, cocaine- and amphetamine-regulated transcript peptide and nesfatin-1 in the mouse Edinger-Westphal nucleus. Brain Res 2010; 1317: 92-99.
15. Yoshida N, Maejima Y, Sedbazar U, Ando A, Kurita H, Damdindorj B, Takano E, Gantulga D, Iwasaki Y, Kurashina T, Onaka T, Dezaki K, Nakata M, Mori M, Yada T. Stressor responsive central nesfatin-1 activates corticotropin-releasing hormone, noradrenaline and serotonin neurons and evokes hypothalamic-pituitary-adrenal axis. Aging (Albany NY) 2010; 2: 775-784.
16. Stengel A, Goebel M, Wang L, Taché Y. Abdominal surgery activates nesfatin-1 immunoreactive brain nuclei in rats. Peptides 2010; 31: 263-270.
17. Bonnet MS, Pecchi E, Trouslard J, Jean A, Dallaporta M, Troadec JD. Central nesfatin-1-expressing neurons are sensitive to peripheral inflammatory stimulus. J Neuroinflammation 2009; 6: 27.
18. Marty N, Dallaporta M, Thorens B. Brain glucose sensing, counterregulation, and energy homeostasis. Physiology (Bethesda) 2007; 22: 241-251.
19. Katafuchi T, Oomura Y, Yoshimatsu H. Single neuron activity in the rat lateral hypothalamus during 2-deoxy-D-glucose induced and natural feeding behavior. Brain Res 1985; 359: 1-9.
20. Ritter S, Dinh TT. 2-Mercaptoacetate and 2-deoxy-D-glucose induce Fos-like immunoreactivity in rat brain. Brain Res 1994; 641: 111-120.
21. Dallaporta M, Himmi T, Perrin J, Orsini JC. Solitary tract nucleus sensitivity to moderate changes in glucose level. NeuroReport 1999; 10: 2657-2660.
22. Yuan PQ, Yang H. Neuroneal activation of brain vagal-regulatory pathways and upper gut enteric plexuses by insulin hypoglycemia. Am J Physiol Endocrinol Metab 2002; 283: E436-E448.
23. Brailoiu GC, Dun SL, Brailoiu E, Inan S, Yang J, Chang JK, Dun NJ. Nesfatin-1:distribution and interaction with a G protein-coupled receptor in the rat brain. Endocrinology 2007; 148: 5088-5094.
24. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press Inc, 2007.
25. Miselis RR, Epstein AN. Feeding induced by intracerebroventricular 2-deoxy-D-glucose in the rat. Am J Physiol 1975; 229: 1438-1447.
26. Stengel A, Goebel M, Yakubov I, Wang L, Witcher D, Coskun T, Taché Y, Sachs G, Lambrecht NW. Identification and characterization of nesfatin-1 immunoreactivity in endocrine cell types of the rat gastric oxyntic mucosa. Endocrinology 2009b; 150: 232-238.
27. Andrey P, Maurin Y. Free-D: an integrated environment for three-dimensional reconstruction from serial sections. J Neurosci Methods 2005; 145: 233-244.
28. Schwarz J, Burguet J, Rampin O, Fromentin G, Andrey P, Tomé D, Maurin Y, Darcel N. Three-dimensional macronutrient-associated Fos expression patterns in the mouse brainstem. PLoS ONE 2010; 5: e8974.
29. McCrimmon RJ. Update in the CNS response to hypoglycemia. J Clin Endocrinol Metab 2012; 97: 1-8.
30. Watts AG, Donovan CM. Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation. Front Neuroendocrinol 2010; 31: 32-43.
31. Routh VH. Glucose sensing neurones in the ventromedial hypothalamus. Sensors (Basel) 2010; 10: 9002-9025.
32. Carrasco M, Portillo F, Larsen PJ, Vallo JJ. Insulin and glucose administration stimulates Fos expression in neurones of the paraventricular nucleus that project to autonomic preganglionic structures. J Neuroendocrinol 2001; 13: 339-346.
33. Briski KP. Intraventricular 2-deoxy-D-glucose induces Fos expression by hypothalamic vasopressin, but not oxytocin neurons. Brain Res Bull 2000; 51: 275-280.
34. Molina PE, Eltayeb K, Hourani H, Okamura K, Nanney LB, Williams P, Abumrad NN. Hormonal and metabolic effects of neuroglucopenia. Brain Res 1993; 614: 99-108.
35. Ritter S, Llewellyn-Smith I, Dinh TT. Subgroups of hindbrain catecholamine neurones are selectively activated by 2-deoxy-D-glucose induced metabolic challenge. Brain Res 1998; 805: 41-54.
36. Briski KP, Marshall ES. Caudal brainstem Fos expression is restricted to periventricular catecholamine neurone-containing loci following intraventricular administration of 2-deoxy-D-glucose. Exp Brain Res 2000; 133: 547-551.
37. McCrimmon R. Glucose sensing during hypoglycemia: lessons from the lab. Diabetes Care 2009; 32: 1357-1363.
38. Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI. Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest 1994; 93: 1677-1682.
39. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 1997; 99: 361-365.
40. Foo KS, Brismar H, Broberger C. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS. Neuroscience 2008; 156: 563-579.
41. Gantulga D, Maejima Y, Nakata M, Yada T. Glucose and insulin induce Ca(2+) signaling in nesfatin-1 neurons in the hypothalamic paraventricular nucleus. Biochem Biophys Res Commun 2012; 420: 811-815.
42. Chen X, Dong J, Jiang ZY. Nesfatin-1 influences the excitability of glucosensing neurons in the hypothalamic nuclei and inhibits the food intake. Regul Pept 2012; 177: 21-26.
43. Taché Y, Yang H, Miampamba M, Martinez V, Yuan PQ. Role of brainstem TRH/TRH-R1 receptors in the vagal gastric cholinergic response to various stimuli including sham-feeding. Auton Neurosci 2006; 125: 42-52.
44. Berthoud HR, Powley TL. Identification of vagal preganglionics that mediate cephalic phase insulin response. Am J Physiol 1990; 258: R523-R530.
45. Berthoud HR, Fox EA, Powley TL. Localization of vagal preganglionics that stimulate insulin and glucagon secretion. Am J Physiol 1990; 258: R160-R168.
46. Riva M, Nitert MD, Voss U, Sathanoori R, Lindqvist A, Ling C, Wierup N. Nesfatin-1 stimulates glucagon and insulin secretion and beta cell NUCB2 is reduced in human type 2 diabetic subjects. Cell Tissue Res 2011; 46: 393-405.
47. Zhang AQ, Li XL, Jiang CY, Lin L, Shi RH, Chen JD, Oomura Y. Expression of nesfatin-1/NUCB2 in rodent digestive system. World J Gastroenterol 2010; 16: 1735-1741.
48. Atsuchi K, Asakawa A, Ushikai M, Ataka K, Tsai M, Koyama K, Sato Y, Kato I, Fujimiya M, Inui A. Centrally administered nesfatin-1 inhibits feeding behaviour and gastroduodenal motility in mice. NeuroReport 2010; 21: 1008-1011.
49. Gonzalez R, Tiwari A, Unniappan S. Pancreatic beta cells colocalize insulin and pronesfatin immunoreactivity in rodents. Biochem Biophys Res Commun 2009; 381: 643-648.
50. Gonzalez R, Reingold BK, Gao X, Gaidhu MP, Tsushima RG, Unniappan S. Nesfatin-1 exerts a direct, glucose-dependent insulinotropic action on mouse islet β- and MIN6 cells. J Endocrinol 2011a; 208: R9-R16.
51. Gonzalez R, Perry RL, Gao X, Gaidhu MP, Tsushima RG, Ceddia RB, Unniappan S. Nutrient responsive nesfatin-1 regulates energy balance and induces glucose-stimulated insulin secretion in rats. Endocrinology 2011b; 152: 3628-3637.
52. Stengel A, Taché Y. Minireview: nesfatin-1-an emerging new player in the brain-gut, endocrine, and metabolic axis. Endocrinology 2011; 152: 4033-4038.
53. Price CJ, Hoyda TD, Samson WK, Ferguson AV. Nesfatin-1 influences the excitability of paraventricular nucleus neurones. J Neuroendocrinol 2008; 20: 245-250.
54. Pałasz A, Krzystanek M, Worthington J, Czajkowska B, Kostro K, Wiaderkiewicz R, Bajor G. Nesfatin-1, a unique regulatory neuropeptide of the brain. Neuropeptides 2012; 46: 105-112.